RxDoctor Payments Data

Carlos Hamilton, MD

Vascular & Interventional Radiology · Sugar Land, TXNPI 1225077308

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.0%), other and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 56.2% of the total. Reporting peaked in 2019 at $26,197 and has fallen 61.8% since, to $10,008 in 2025.

$46,132in general payments, 2019–2025

Across 94 payments — averaging $490.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$26K
  • Angiodynamics, Inc.$18K
  • Bard Peripheral Vascular, Inc.$611
  • Boston Scientific$553
  • Tactile Systems Technology Inc$336
  • Biocompatibles, Inc.$198
  • plus $313 from 8 others

What the payments were for

  • Royalty or licence$25,85756%
  • Food & beverage$2,1965%
  • Other$18,08039%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)6$25,942
Angiodynamics, Inc.11$18,180
Bard Peripheral Vascular, Inc.17$611
Boston Scientific26$553
Tactile Systems Technology Inc19$336
Biocompatibles, Inc.4$198
Globus Medical1$114
Venclose Inc.1$44
Cashflow Solutions, LLC3$38
Nevro Corp.1$33
Smith+Nephew2$32
Inspire Medical Systems, Inc.1$27
Johnson & Johnson1$15
Wound Management Technologies, Inc1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,132 in reported general payments places this provider in the 85th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas

Medicare billing

Part B allowed, 2024
$899,921
Medicare patients
209
Services billed
1,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Sugar Land

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →